adenosine monophosphate has been researched along with glucagon-like peptide 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, N; Lu, J; Willars, GB | 1 |
| Basta, G; Calafiore, R; Luca, G; Mazzieri, A | 1 |
1 review(s) available for adenosine monophosphate and glucagon-like peptide 1
| Article | Year |
|---|---|
GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents | 2023 |
1 other study(ies) available for adenosine monophosphate and glucagon-like peptide 1
| Article | Year |
|---|---|
Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor.
Topics: Adenosine Monophosphate; Allosteric Regulation; Animals; Biotransformation; Calcium; Calcium Signaling; Cell Line; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Insulin; Peptide Fragments; Peptides; Quinoxalines; Rats; Receptors, Glucagon; Sulfones; Transfection | 2012 |